TY - JOUR
AU - Ziegler, John B.
AB - Abstracts Summary: A total of 73% measured >8 g/L IgG prior to transfer to SCIg Department of Immunology, School of Medicine, Tehran University infusion. A total of 78% measured >8 g/L on SCIg. Less numbers of of Medical Sciences, Tehran, Iran syringe driver users (83%) on SCIg achieved >8 g/L compared to this CeMM Research Center for Molecular Medicine of the Austrian group pre-SCIg. Those who transferred to rapid push administration Academy of Sciences, Vienna, Austria achieved >8 g/L in 49% increased to >8 g/L for 67% of samples. A Department of Pediatrics and Adolescent Medicine, Medical decrease of samples >8 g/L was shown for the subset groups with and University of Vienna, Vienna, Austria without bronchiectasis once SCIg commenced. This occurred similarly in The Hyper-immunoglobulin M syndromes (HIGM) or immunoglobulin both syringe driver and rapid push groups. class switch recombination (Ig-CSR) deficiencies are rare primary immu- Conclusion: There was a small increase of overall IgG trough levels for nodeficiency (PID) disorders. A 9-year-old girl with recurrent ear infec- both syringe driver and rapid push infusions. Patients on rapid push tions and failure to thrive since the age of 6 months had normal showed significant increase in levels. Both 
TI - ASCIA‐P68: PATIENT PERSPECTIVES AND FOLLOW‐UP ARRANGEMENTS POST HSCT FOR SEVERE COMBINED IMMUNODEFICIENCY
JF - Internal Medicine Journal
DO - 10.1111/imj.68_13197
DA - 2016-09-01
UR - https://www.deepdyve.com/lp/wiley/ascia-p68-patient-perspectives-and-follow-up-arrangements-post-hsct-J30jFSxyLe
SP - 26
EP - 26
VL - 46
IS - 
DP - DeepDyve
ER -